INS and metabolic disease: Reduced insulin sensitivity is considered as a significant risk factor for atherosclerotic disease (36), and serves as a central contributor to cardiovascular risk factors such as visceral obesity, atherogenic dyslipidemia, and hypertension, which frequently co-occur in individuals with metabolic disorders (37).